Document Detail


Cardiac sensitization: methodology and interpretation in risk assessment.
MedLine Citation:
PMID:  12878057     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An increased sensitivity of the heart to endogenous epinephrine (adrenaline), a phenomenon referred to as cardiac sensitization, has long been recognized as a risk during exposure to hydrocarbons, principally halogenated hydrocarbons. Cardiac sensitization, which can result in serious arrhythmia and death, requires a certain critical blood level of both the sensitizing agent and epinephrine. The original research and methods utilized an exogenous epinephrine challenge during inhalation exposure to a chemical to assess cardiac sensitization potential in Beagle dogs. These screening tests were developed about 30 years ago, although in the last 15 years some modifications of these methods have occurred in response to testing chlorofluorocarbon (CFC) replacements. Results from these experimental cardiac sensitization studies have been used for semi-quantitative risk evaluation for occupational exposures but now are being used more quantitatively for regulatory purposes. The risks associated with cardiac sensitization from CFC replacements are unknown but expected to be low based on cardiac sensitization studies in the 1970s where dogs were made to generate their own adrenaline. With the advent of physiologically based pharmacokinetic (PBPK) modeling, greater emphasis is being placed on quantitative risk assessment for cardiac sensitization. In this investigation, we have examined the various methodologies used for detection of cardiac sensitization and discussed their limitations and advantages. In addition, we examined the potential concerns involved in using experimental cardiac sensitization data and PBPK modeling to predict exposure scenarios.
Authors:
William J Brock; George M Rusch; Henry J Trochimowicz
Related Documents :
6929617 - Selective mitochondrial alterations induced by a single dose of daunorubicin or 4-demet...
9013467 - Visualization of the lymphatics of the heart and the mediastinal drainage pathways in t...
1487897 - A constitutive theory for biomembranes: application to epicardial mechanics.
25305307 - Alpha-catenins control cardiomyocyte proliferation by regulating yap activity.
21723447 - Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management.
15523547 - Myocardial revascularisation in patients with severe left ventricular dysfunction. earl...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Regulatory toxicology and pharmacology : RTP     Volume:  38     ISSN:  0273-2300     ISO Abbreviation:  Regul. Toxicol. Pharmacol.     Publication Date:  2003 Aug 
Date Detail:
Created Date:  2003-07-24     Completed Date:  2004-06-21     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8214983     Medline TA:  Regul Toxicol Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  78-90     Citation Subset:  IM    
Affiliation:
ENVIRON Institute for Health Risk Sciences, 4350 N. Fairfax Drive, Suite 300, Arlington, VA 22203, USA. wbrock@environcorp.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Animals
Dose-Response Relationship, Drug
Epinephrine / metabolism*,  toxicity
Heart Diseases / chemically induced*,  metabolism
Humans
Hydrocarbons, Halogenated / adverse effects*,  blood,  pharmacokinetics
Models, Animal
Myocardium / metabolism
Risk Assessment
Time Factors
Chemical
Reg. No./Substance:
0/Hydrocarbons, Halogenated; 51-43-4/Epinephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reduction of the biological potential of chrysotile asbestos arising from conditions of service on b...
Next Document:  The effect of the 14-day agricultural restricted entry interval on azinphosmethyl exposures in a gro...